Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1193-1198

  Wensel, Roland ^a,b   Francis, Darrel P ^a   Meyer, F Joachim ^c   Opitz, Christian F ^d   Bruch, Leonhard ^e   Halank, Michael ^f   Winkler, Jörg ^g   Seyfarth, Hans Jürgen ^h   Gläser, Sven ⁱ   Blumberg, Friedrich ^j   Obst, Anne ⁱ   Dandel, Michael ^k   Hetzer, Roland ^k   Ewert, Ralf ⁱ  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d German Red Cross Hospital   (Germany)

^e UNFALLKRANKENHAUS BERLIN   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g Praxis für Pneumologie/Allergologie ^*  (Germany)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ UNIVERSITY OF GREIFSWALD   (Germany)

^j PROSPER HOSPITAL   (Germany)

^k DEUTSCHES HERZZENTRUM BERLIN   (Germany)

more..

Author keywords

Cardiopulmonary exercise testing; Haemodynamics; Prognosis; Pulmonary arterial hypertension

Indexed keywords

ANTICOAGULANT AGENT; BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; OXYGEN; SILDENAFIL;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART RATE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESTING HEMODYNAMICS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TERTIARY HEALTH CARE;

CARDIOPULMONARY EXERCISE TESTING; HAEMODYNAMICS; PROGNOSIS; PULMONARY ARTERIAL HYPERTENSION;

ADULT; COHORT STUDIES; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REST; TIME FACTORS;

EID: 84881475020     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.135     Document Type: Article

References (31)

1. T. Thenappan, S.J. Shah, and S. Rich Contemporary survival in patients with pulmonary arterial hypertension: a reappraisal of the National Institutes of Health risk stratification equation Eur Respir J 35 2010 1079 1087
2. V.V. McLaughlin, O. Sitbon, and D.B. Badesch Survival with first-line bosentan in patients with primary pulmonary hypertension Eur Respir J 25 2005 244 249
3. V.V. McLaughlin, R.J. Oudiz, and A. Frost Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension Am J Respir Crit Care Med 174 2006 1257 1263
4. M.M. Hoeper, I. Markevych, E. Spiekerkoetter, T. Welte, and J. Niedermeyer Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Eur Respir J 26 2005 858 863
5. N. Galiè, M.M. Hoeper, and M. Humbert ESC Committee for Practice Guidelines (CPG) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
6. O. Okada, N. Tanabe, and J. Yasuda Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980-1990 Intern Med 38 1999 12 16
7. H.H. Leuchte, M. El Nounou, and J.C. Tuerpe N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension Chest 131 2007 402 409
8. S. Miyamoto, N. Nagaya, and T. Satoh Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing Am J Respir Crit Care Med 161 2000 487 492
9. S.J. Shah, T. Thenappan, S. Rich, J. Sur, S.L. Archer, and M. Gomberg-Maitland Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension Circ Heart Fail 2 2009 278 286
10. H. Groepenhoff, A. Vonk-Noordegraaf, A. Boonstra, M.D. Spreeuwenberg, P.E. Postmus, and H.J. Bogaard Exercise testing to estimate survival in pulmonary hypertension Med Sci Sports Exerc 40 2008 1725 1732
11. X.G. Sun, J.E. Hansen, R.J. Oudiz, and K. Wasserman Exercise pathophysiology in patients with primary pulmonary hypertension Circulation 104 2001 429 435
12. R. Wensel, C.F. Opitz, and S.D. Anker Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing Circulation 106 2002 319 324
13. S. Rich, D.R. Dantzker, and S.M. Ayres Primary pulmonary hypertension. A national prospective study Ann Intern Med 107 1987 216 223
14. G. Simonneau, I.M. Robbins, and M. Beghetti Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
15. R.J. Barst, M. McGoon, and A. Torbicki Diagnosis and differential assessment of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 40S 47S
16. K. Wasserman, J.E. Hansen, D.Y. Sue, W. Stringer, and B.J. Whipp Normal values R. Weinberg, Principles of exercise testing and interpretation 4th ed. 2005 Lippincott Williams and Wilkins Philadelphia, PA 160 182
17. J.E. Hansen, D.Y. Sue, and K. Wasserman Predicted values for clinical exercise testing Am Rev Respir Dis 129 1984 S49 S55
18. R. Arena, J. Myers, and J. Abella Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure Circ Heart Fail 2 2009 113 120
19. W.L. Beaver, K. Wasserman, and B.J. Whipp A new method for detecting anaerobic threshold by gas exchange J Appl Physiol 60 1986 2020 2027
20. C.G. LaFarge, and O.S. Miettinen The estimated of oxygen consumption Cardiovasc Res 4 1970 23 30
21. European community for steel and coal standardized lung function testing Eur Respir J 6 1993 1 100
22. 2 abnormality and exercise limitation in patients with primary pulmonary hypertension Chest 127 2005 1637 1646
23. R. Bauer, C. Dehnert, and P. Schoene Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension Respir Med 101 2007 2366 2369
24. F.J. Meyer, D. Lossnitzer, and A.V. Kristen Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension Eur Respir J 25 2005 125 130
25. A.J. Coats The muscle hypothesis of chronic heart failure J Mol Cell Cardiol 28 1996 2255 2262
26. P.D. Wagner Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy? Respirology 11 2006 681 686
27. S. Velez-Roa, A. Ciarka, B. Najem, J.L. Vachiery, R. Naeije, and P. van de Borne Increased sympathetic nerve activity in pulmonary artery hypertension Circulation 110 2004 1308 1312
28. R. Wensel, C. Jilek, and M. Dörr Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension Eur Respir J 34 2009 895 901
29. I.R. Henkens, S.A. Van Wolferen, and C.T. Gan Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension Am J Cardiol 103 2009 1451 1456
30. R.L. Benza, D.P. Miller, and M. Gomberg-Maitland Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 164 172
31. M. Humbert, O. Sitbon, and A. Chaouat Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163